- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Patients With Multiple Sclerosis in United Kingdom
Total 1675 results
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple SclerosisUnited States
-
EMD SeronoPfizerCompletedRelapsing Remitting Multiple Sclerosis (RRMS)United States
-
Nottingham University Hospitals NHS TrustUnknown
-
University of Alabama at BirminghamWashington University School of Medicine; United States Department of DefenseRecruitingRelapsing Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Queen Mary University of LondonBiogen; Barts & The London NHS Trust; Moorfields Eye Hospital NHS Foundation... and other collaboratorsRecruitingMultiple Sclerosis | Clinically Isolated Syndrome of DemyelinationUnited Kingdom
-
Nationwide Children's HospitalCompletedPatients Undergoing ENT Surgery With Cuffed ETTUnited States
-
Joseph D. TobiasCompletedPatients Intubated With a Cuffed Endotracheal TubeUnited States
-
AllerganCompletedPatients With Moderate to Severe Perioral LinesUnited States
-
Sheffield Teaching Hospitals NHS Foundation TrustJP Moulton Charitable FoundationCompleted
-
Sheffield Teaching Hospitals NHS Foundation TrustTerminatedPatients With Coeliac Disease and Chronic Diarrhoea (>3 Loose/ Liquid Motions a Day for More Than 4 Weeks) | Patients With Pancreatic Exocrine InsufficiencyUnited Kingdom
-
University of EdinburghNHS LothianEnrolling by invitationMultiple SclerosisUnited Kingdom
-
TeleflexCompletedAdult Patients With Peripherally Inserted Central CathetersUnited States
-
University of Massachusetts, LowellOhio State UniversityCompletedHemiparesis | Primary Progressive Multiple SclerosisUnited States
-
Gamida Cell ltdCompletedPatients Transplanted With NiCord/CordIn (Omidubicel)United States, Singapore, Spain, Netherlands
-
City, University of LondonUniversity College London HospitalsCompletedMultiple SclerosisUnited Kingdom
-
Hoffmann-La RochePPDRecruitingRelapsing-Remitting Multiple SclerosisUnited States, Belgium, Canada, Spain, India, Italy, Mexico, Portugal, Argentina, Austria, Brazil, United Kingdom, Germany, Netherlands, Serbia, Australia, Bulgaria, France, Greece, Hungary, Poland, Ukraine, Estonia, Denmark, Croatia, Latvia and more
-
SanofiRecruitingRelapsing Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Progressive Relapsing Multiple SclerosisChina, Turkey, Korea, Republic of, United States, Ukraine
-
EMD Serono Research & Development Institute, Inc.CompletedRelapsing-Remitting Multiple SclerosisCroatia, United States, Bulgaria, France, Italy, Russian Federation, Turkey, United Kingdom, Estonia, Germany, Latvia, Lithuania, Poland, Austria, Brazil, Canada, Finland, Portugal, Greece, Serbia, Denmark, Ukraine, Saudi Arabia, Lebanon and more
-
Institute for Clinical ResearchUnknownRelapsing-Remitting Multiple SclerosisUnited States
-
University of CambridgeCambridge University Hospitals NHS Foundation Trust; Medical Research CouncilCompleted
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisCroatia, United States, Czech Republic, France, Italy, Mexico, South Africa, United Kingdom, Germany, Poland, Romania, Ukraine, Netherlands, Austria, Canada, Israel, New Zealand, Slovakia, Greece, Serbia, India, Belgium, Switzerland, ... and more
-
Celestra Health SystemsBrigham and Women's Hospital; The Ottawa Hospital; Barts & The London NHS Trust; University of OttawaRecruitingMultiple SclerosisUnited States, Canada, United Kingdom
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple SclerosisUnited States
-
Genzyme, a Sanofi CompanyTerminatedRelapsing-remitting Multiple SclerosisRussian Federation, United States, Canada, Poland
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisPoland, Hungary, United States, Czech Republic
-
Massachusetts General HospitalRecruitingPediatric Patients Treated With Radiation TherapyUnited States
-
Queen Mary University of LondonActive, not recruiting
-
Abramson Cancer Center of the University of PennsylvaniaTerminatedSubjects With Severe, Refractory Sclerotic Skin ChangesUnited States
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisUnited States, France, Germany, Spain, Belgium, Czechia, Switzerland, United Kingdom, Austria, New Zealand, Australia, South Africa, Ukraine, Italy, Slovakia, Greece, Poland, Israel, Netherlands, Bulgaria, Serbia, India, Romania, Estonia and more
-
University of LouisvilleRecruitingRelapsing Remitting Multiple SclerosisUnited States
-
Johns Hopkins UniversityGlaxoSmithKlineTerminatedMultiple SclerosisUnited States
-
Johns Hopkins UniversityCompletedRelapsing Remitting Multiple SclerosisUnited States
-
BiogenAbbVieTerminatedMultiple Sclerosis | Relapsing-Remitting Multiple SclerosisUnited States, Denmark, Italy, United Kingdom, Czechia, Canada, Hungary, Spain, Australia, Israel, Georgia, Serbia, Russian Federation, Ukraine, India, Poland, Brazil, France, Argentina, Germany, Greece, Ireland, Mexico, Moldova, Republic... and more
-
Genzyme, a Sanofi CompanyTerminatedRelapsing-remitting Multiple SclerosisSweden, Poland, Russian Federation, United States, Canada
-
University of MichiganCompleted
-
University at BuffaloBiogenCompletedMultiple SclerosisUnited States
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedRelapsing-Remitting Multiple SclerosisUnited States
-
The Cleveland ClinicUniversity of NottinghamActive, not recruitingMultiple Sclerosis, Relapsing-RemittingUnited States, United Kingdom
-
MSDx, Inc.CompletedRelapsing Remitting Multiple SclerosisUnited States
-
OhioHealthCompletedRelapsing Remitting Multiple SclerosisUnited States
-
Revalesio CorporationWithdrawnRelapsing Remitting Multiple SclerosisUnited States
-
University of Wisconsin, MadisonCompletedRelapsing Remitting Multiple SclerosisUnited States
-
Alabama Neurology Associates, PCBiogenUnknownRelapsing Remitting Multiple SclerosisUnited States
-
Multiple Sclerosis InstituteUnknown
-
Shirley Ryan AbilityLabNorthwestern UniversityNot yet recruitingMultiple Sclerosis | Multiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary ProgressiveUnited States
-
Icahn School of Medicine at Mount SinaiWithdrawnRelapsing-remitting Multiple Sclerosis (RRMS)United States
-
Johns Hopkins UniversityCompletedProgressive Multiple SclerosisUnited States
-
Indiana UniversityUniversity of Alabama at Birmingham; University of OttawaCompletedProgressive Multiple SclerosisUnited States
-
National Institute of Allergy and Infectious Diseases...CompletedMultiple Sclerosis | Primary Progressive Multiple SclerosisUnited States
-
Rocky Mountain MS Research Group, LLCBiogenCompletedRelapsing Remitting Multiple SclerosisUnited States